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Calcium is a major second messenger in neurons and modulates many neuronal functions,
including protein phosphorylation, phospholipid metabolism, cytoskeletal activity, and neuro-
transmitter release. These important events, which regulate neuronal activity, are directly
dependent on the influx of extracellular calcium through voltage-sensitive calcium channels
(VSCCs) in the neuronal membrane. Modulation of VSCC function represents an important
strategy for regulating neuronal excitability. Although substantial evidence supports the ability of
dihydropyridines to block VSCCs and contractility in cardiovascular tissue, their ability to block
the majority of neuronal VSCCs remains controversial. Benzodiazepines, and other anticonvul-
sants, block depolarization-dependent 45Ca uptake through VSCCs in brain synaptosome
preparations. In addition, benzodiazepines reduce voltage-gated calcium conductance as deter-
mined by voltage clamp studies of identified invertebrate neurons. Inhibition of VSCC activity
may be an important mechanism by which these compounds produce their anticonvulsant and
sedative effects. Intrasomal injection ofcalcium-calmodulin-dependent protein kinase modulates
calcium conductance in invertebrate neurons, suggesting that protein phosphorylation may be an
endogenous regulatory mechanism of VSCC activity. Developing novel pharmacological
approaches to regulating VSCCs and understanding the endogenous regulatory mechanisms may
lead to new therapeutic approaches to the treatment of neurological diseases.
Calcium is an important mediator ofmolecular events in neurons [1]. An increase in
cytoplasmic Ca2, in response to depolarization has been shown to modulate numerous
neuronal functions, including synaptic morphological changes, stimulation of protein
phosphorylation, and neurotransmitter release [2]. These events aredirectly dependent
on the entry of extracellular Ca2+ ions into the presynaptic nerve terminal through
specificvoltage-sensitive Ca2, channels (VSCC) [3]. This central role ofCa2, channel
function in neuronal activity, and in stimulus-secretion coupling phenomena, has led to
extensive investigation of Ca2, channel function in a wide variety of tissues [1,4].
Thesestudies have led tothe understanding that VSCCs are a heterogenous population
ofmembrane channels with different pharmacological and physiological properties. In
spite of extensive biochemical and electrophysiological characterization of Ca2+
channels in brain, however, the molecular nature and pharmacological properties of
neuronal Ca2, channels remain largely unclear.
VOLTAGE-SENSITIVE CALCIUM CHANNELS
The properties of Ca2, channels in some non-neuronal tissues, particularly in the
heart and vascular smooth muscle, have been extensively studied [5]. Ca2+ regulates
muscle function and contractility in both smooth and cardiacmuscle. As in brain, some
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Ca2" channels in these tissues are voltage-sensitive, although Ca2" influx can also be
modulated by neurotransmitters, hormones, and various drugs through receptor-
operated channels [6]. Both of these types of Ca2" channels are blocked by polyvalent
cations such as Mn2", Co2 , and La3+. Several distinct classes oforganic Ca2+ channel
blockers have been identified in cardiovascular systems, including verapamil, diltia-
zem, and the dihydropyridines, nitrendipine, nisoldipine, and nimodipine. The ability
of the dihydropyridines to act as VSCC antagonists has led to their clinical use in the
treatment of cardiac arrhythmias, hypertension, and other cardiovascular disorders.
Furthermore, these drugs have been used as specific pharmacological probes for the
molecular study of Ca2+ channels in heart and smooth muscle preparations. High-
affinity [3H]nitrendipine binding sites, which have been identified and characterized
in ileal smooth muscle, have binding properties that correlate well with nitrendipine
inhibition ofCa2+ flux [7]. Although some variations between preparations have been
observed, the pharmacological correlation between nitrendipine binding and nitrendi-
pine inhibition of Ca2+ uptake suggests that [3H]nitrendipine binding sites may
represent VSCCs in cardiovascular and smooth muscle tissue.
In brain and other neuronal tissues, voltage-sensitive Ca2, channels are also blocked
by polyvalent cations such as Mn2+, Co2+, and La3+. Because of the success of
verapamil and the dihydropyridines as Ca2+ channel probes in cardiac and smooth
muscle, these compounds have been employed to study Ca2+ channels in brain. In brain
preparations, specific high-affinity [3H]nitrendipine binding sites have been observed
which have pharmacological properties almost identical to those found in the heart [8];
however, the effectiveness of these drugs as Ca2+ channel blockers in brain seems to be
substantially different. Organic Ca2" antagonists are relatively ineffective blockers of
voltage-sensitive Ca2+ uptake in synaptosomes [9] at concentrations where binding to
[3H]nitrendipine receptors is maximal. Although some studies have appeared which
show dihydropyridine inhibition of Ca2+ uptake in cultured neuronal cell lines,
nitrendipine does not block neurotransmitter release in these cells or neurons. Recent
studies have shown that fast-phase Ca2+ uptake (<1 second) in synaptosomes is
inhibited by nitrendipine in Na+-free media [10], but its effect was incomplete and
may not be associated with inhibition of neurotransmitter release. These observations
suggest that the functional characteristics of Ca2+ channels in neuronal tissue are
extremely complex and that multiple types of Ca2+ channels, which have different
pharmacological properties, may exist. Future studies ofVSCCs in neuronal tissue will
center on electrophysiological characterization where subtle functional differences can
be detected.
Although the molecular properties of Ca2+ channels in brain are controversial, the
central role of VSCCs in brain function remains unchallenged. Pharmacological
manipulation of VSCC activity potentially provides an important mechanism for
modulating neuronal function, as has been successfully achieved with Ca2+ channel
modulators in cardiovascular systems. This review will examine the evidence that
certain anticonvulsant compounds, including the benzodiazepines, diphenylhydantoin
and carbamazepine, modulate Ca2+ channel function in brain, and that this action may
represent an important mechanism by which these compounds produce their anti-
convulsant and sedative effects.
ANTICONVULSANT INHIBITION OF SYNAPTOSOMAL
CALCIUM UPTAKE
Anticonvulsants are a complex class of neuroactive compounds which have numer-
ous effects on cells, including alteration of growth properties, energy metabolism,
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enzyme activity, and neurotransmitter secretion. Since anticonvulsants produce multi-
ple clinical effects as well, it is important to examine the effects of these compounds on
the biochemical level to identify their precise mechanisms of action. Benzodiazepines
(BZs) have been shown to bind to high-affinity BZ receptors in brain [11]. These
central BZ receptors exist as a complex with GABA receptors and chloride ionophores
such that, on BZ binding to its receptor, a hyperpolarizing increase in chloride flux
occurs. The pharmacological characteristics of BZ binding to the high-affinity central
BZ receptor correlate well with BZ anxiolytic effects and BZ inhibition of
pentylenetetrazol-induced seizure activity, suggesting that these effects are mediated
through BZ binding at this receptor site. However, other therapeutic effects of BZs do
not correlate with binding to this site, such as BZ inhibition of maximal electric
shock-induced seizures, suggesting that BZs have other physiological effects. We have
investigated the possibility that the neuronal stabilizing properties of BZs and other
anticonvulsants are produced by modulation ofCa2" uptake parameters in neurons.
Several lines of evidence suggest that anticonvulsants modulate Ca2'-dependent
mechanisms in neurons and led to investigation of the role of anticonvulsants in
altering VSCC function. Several types of anticonvulsant compounds, including the
benzodiazepines, diphenylhydantoin and carbamazepine, have been shown to block
Ca2" uptake in nerve terminal preparations [12,13,14]. In addition, these compounds
inhibit Ca2'-dependent neurotransmitter release in synaptosomes [2], indicating that
they regulate functionally significant Ca2" influx. Since this action may represent a
physiologically relevant anticonvulsant or sedative mechanism, we have examined
more precisely the ability of the benzodiazepines to act as Ca2" channel blockers in
brain.
To investigate the effects of BZs on synaptosomal Ca2+ uptake,45Ca flux was
monitored under both depolarized and non-depolarized conditions [14]. Under these
experimental conditions, Ca2+ flux consists of both Ca2, uptake into the synaptosomal
cytoplasm as well as Ca2+ efflux. BZs, in micromolar concentrations (50-200,uM),
block the45Ca uptake component ofCa2, flux and show no effect on Ca2+ efflux under
these conditions (Fig. 1). BZs inhibit the rapid phase of depolarization-sensitive 45Ca
uptake (<5 seconds) and have no significant effect on control (non-depolarized)
synaptosomes. Synaptosomal depolarization can be induced either by the presence of
high K+ levels (30-70 mM) or veratridine (50 ,tM), and both result in Ca2+
accumulation which is BZ-sensitive. Under these depolarizing conditions, synapto-
somal Ca2+ uptake proceeds down its concentration gradient through voltage-sensitive
Ca2, channels and Na+ channels. The Na+ channel blocker, tetrodotoxin (TTX),
effectively blocks veratridine-induced 45Ca uptake, but TTX does not inhibit high
K+-induced 45Ca uptake, nor does it affect BZ inhibition of high K+-induced 45Ca
uptake. Thus, BZ-sensitive45Ca uptake in depolarized synaptosomes is not mediated
by TTX-sensitive Na+ channels and is probably associated with voltage-sensitive Ca2+
channels. In support of this conclusion, we observed that BZ-sensitive45Ca uptake is
also sensitive to the Ca2, channel blockers Mn2" and Co2,. In summary, the
biochemical evidence suggests that the nature of BZ inhibition of Ca2' accumulation
in synaptosomes represents blockage of Ca2+ uptake induced by depolarization and
mediated byvoltage-sensitive Ca2+ channels. Thus, BZs act like Ca2+ channel blockers
in synaptosomes.
BENZODIAZEPINE INHIBITION OF CALCIUM CONDUCTANCE
IN LEECH NEURONS
Since numerous factors can influence45Ca uptake in synaptosomal fractions, we
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initiated a series ofelectrophysiological investigations to complement the biochemical
studies using synaptosomes [15]. These investigations were designed to test the
hypothesis that benzodiazepines block voltage-gated Ca2" channels in intact inverte-
brate neurons. Weemployed established techniques in identified cells selected for their
well-studied Ca2" currents. Our initial efforts in this direction involved the use of
intracellular recording techniques in identified nociceptive neurons (N cells) of the
leech Macrobdella decora.
To determine the electrophysiological effects of BZs on Ca2" conductance, we
studied the actions of these compounds on the long-lasting regenerative Ca2" potential
revealed by blocking outwardK+ currents in identified N cells [15]. These neurons
possess Mn2+- and Co2"-sensitive divalent cation potentials which have the same
properties as Ca2" channels described in other neuronal preparations from vertebrate
and invertebratephyla. We observed that, in ,uM concentrations, BZs reversibly inhibit
voltage-dependent Ca2" conductance in adose-dependent manner, indicating that BZs
act as Ca2" channel blockers (Fig. 2). Like Mn2+, BZs inhibit the maximum rate of
depolarization (Vmax) and duration of the Ca2, potentials. This inhibitory effect was
observed at BZ concentrations that do not significantly affect the resting membrane
potential or Vmax of theNa+-dependent action potential. These findings suggest that
BZs are not acting non-specifically or like local anesthetics, but may selectively affect
theCa2+ channel in these neurons ofthe leech. The apparent Ki for BZ inhibition ofthe
N cell Ca2, conductance correlated well with the IC50 values for BZ inhibition of
synaptosomal45Ca uptake. These findings are consistent with the hypothesis that BZs
regulate voltage-sensitive Ca2, channels and that this effect may play a role in
anticonvulsant regulation of neuronal excitability.
BENZODIAZEPINES REDUCE VOLTAGE-GATED CALCIUM
CONDUCTANCE IN HERMISSENDA NEURONS
The data from the electrophysiological studies in the leech do not preclude the
possibility that BZs may have effects on other ion conductances. It is important to
investigate the effects of BZs on other model systems using voltage clamp technology
to determine moreaccurately their role as neuroactive agents. Thus, we have examined
the effects of BZs on Ca2+ conductance under voltage clamp conditions in identified
neurons from the sea snail Hermissenda crassicornis.
We used conventional two-electrodevoltage clamp techniques to examine the effects
of BZs on a Ca2, conductance (ICa) in identified Hermissenda neurons [16].ICa was
measured in agiantpedal neuron (LP1) bathed in 0Na+ artificial seawater containing
100 mMtetraethylammonium (TEA) and 3 mM 4-aminopyridine (4-AP) to eliminate
Na+ and K+ conductances. Ba2' replaced Ca2' as the current carrier to maximize
current carried and eliminate Ca2'-activated outward K+ conductance (Ic). Previous
studies have demonstrated that current carried under these conditions is sensitive to
other ionic blockers of neuronal voltage-gated Ca2, channels, including Mn2' and
Co2,. We observed that micromolar concentrations of bath-applied diazepam or
medazepam substantially reduced ICa in a dose-dependent manner. Inhibition ofICa
was reversible (1-2 minutes). Vehicle (ethanol, 0.5 percent) alone had no effect.
Similar results were obtained in other identified cells in the pedal ganglion and in
photoreceptor cells of the Hermissenda eye. These data suggest that BZs reduce the
inward Ca2+ current in Hermissenda neurons. This result is consistent with the
biochemical and electrophysiological data previously obtained, indicating that BZs
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FIG. 1. Effects ofdiazepam (DZ) on synaptosomal 45Ca uptake (A)
and efflux (B). A. Data show 45Ca uptake in depolarizing (70 mM
K+) conditions in the presence (solid circles) and absence (open
circles) of 150 ,uM DZ. DZ inhibits Ca2" uptake at all time points
studied. B. The effect of DZ on 45Ca efflux from preloaded
synaptosomes was determiend in the presence (solid circles) and
absence (open circles) of 150 MM DZ. No effect of DZ on Ca2" efflux
is evident. All data areexpressed as percentages of maximal 45Ca (n =
8; error bars, mean ± SEM). Taken from [14].
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FIG. 2. Effects of medazepam
(MDZ) and Mn2" on Sr2" potentials in
lateral N cells ofthe leech. Dose-depen-
dent inhibition of the divalent cation
conductance by MDZ (A) and Mn2"
(B) was obtained in Na+-free/TEA/
Ringers solution. A similar pattern of
Ca2" channel inhibition was observed.
Taken from [15].
20 mV
I Sec
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function as neuronal Ca2" channel blockers. Thus, based on 45Ca uptake studies in
synaptosomes, intracellular recording of Ca2" potentials in the leech, and voltage
clamp recording of Ca2" conductance in Hermissenda, BZs inhibit neuronal VSCC.
Future studies will examine the role of other putative Ca2" channel blockers in these
model systems, as well as BZ effects on other ionic currents.
EFFECTS OF CaM KINASE II ON CALCIUM CONDUCTANCES
IN HERMISSENDA NEURONS
Although substantial evidence suggests that neuronal Ca2" channels are sensitive to
BZs, the mechanism by which these compounds exert their inhibitory effect is
unknown. The BZs may act directly on the channel itself or might affect VSCC via a
known regulator of channel function. Recent studies have examined putative mecha-
nisms that might be involved in the in vivo regulation of VSCC function. It has been
well-described that cellular second messengers, such as cAMP and Ca2", and
neurotransmitters and hormones acting through these messengers, can modulate ion
channel function [6]. Initial efforts to identify the endogenous mechanisms that
regulate ion channels investigated the role of cAMP in regulating conductances in
heart cells and demonstrated that cAMP-dependent protein kinase may mediate the
effects ofcAMP on these conductances [4]. This work established the concept that the
activity of specific ion channels in the membrane can be modulated by intracellular
second messengers activating protein phosphorylation pathways.
Since Ca2" plays a major role in regulating excitability in the nervous system,
subsequent studies have investigated the ability ofCa2"-regulated protein kinases, and
particularly calcium-calmodulin-stimulated protein kinase (CaM kinaseII), to modu-
late ion channel activity [17]. The recent purification and characterization of CaM
kinase
II makes it possible to determine directly the effects of purified kinase on
identified Ca2" conductances in intact neurons. The potential role of CaM kinase II in
regulating Ca2" conductances is particularly interesting in light of the fact that BZs
inhibit CaM kinase II activity [18,19] and may thus be a mechanism for BZ inhibition
ofCa2" channel function.
Results from our laboratory, in collaboration with Dr. Daniel Alkon, have shown
that injection of highly purified CaM kinase II reduces Ca2" current in Hermissenda
photoreceptor cells [17]. In these studies, CaM kinase II is injected intracellularly into
Hermissenda neurons, and its effect on ion conductances is documented electrophysio-
logically using voltage clamp techniques. ICa was observed with 3 mM 4-AP, 100 mM
TEA, and Ba2+ substituting for Ca2+ as the current carrier, as performed previously. A
single injection of CaM kinase II was followed by a significant reduction of ICa. This
reduction was enhanced by the presence of increased intracellular Ca2, levels,
presumably due to increased kinase activity under those conditions. Similar results
were not obtained when heat-inactivated enzyme was injected. These effects of CaM
kinase
II appear to be an amplification of a regulatory mechanism already existing
within the Hermissenda photoreceptor cell. These observations are consistent with the
hypothesis that CaM kinase II may modulate VSCC activity in neurons. A hypotheti-
cal model might suggest that neuronal firing leads to increased intracellular Ca2,
levels and formation of the activated Ca2+-calmodulin complex. This process activates
CaM kinase II which can then phosphorylate either the VSCC itself or a regulator of
VSCC activity to reduce channel activity. Although the effects of CaM kinase II were
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not exclusive to ICa (two outward K+ currents were also affected), this may represent
an important mechanism by which neurons regulate excitability.
SUMMARY
The variation in potency of dihydropyridines and other Ca2" channel blockers
between neuronal and non-neuronal tissues suggests that VSCCs are a heterogenous
population ofmembrane channels with different pharmacological properties. Whether
these differences reflect diversity of the molecular composition of VSCCs, a complex
setofconformational states, or alterations in theregulation ofVSCC activity remain to
be determined. Benzodiazepines and other anticonvulsants are effective inhibitors of
some types of Ca2" channel activity as determined in biochemical and electrophysio-
logical models. This action may represent the biochemical mechanism by which these
compounds elicit their sedative and anticonvulsant properties. In addition, protein
phosphorylation regulates certain types of Ca2" channels as demonstrated by CaM
kinase II modVlation ofCa2" conductance in invertebrate neurons. Understanding the
molecular mechanisms mediating Ca2" flux and how it is regulated endogenously and
by neuroactive compounds is an important goal of neuroscience and may provide new
therapeutic interventions for neurological diseases.
REFERENCES
1. Rubin RP: The role ofcalcium in the release ofneurotransmitter substances and hormones. Pharmacol
Rev 22:389-428, 1972
2. DeLorenzo RJ: Calmodulin in neurotransmitter release and synaptic function. Fed Proc 41:2265-2272,
1982
3. Katz B, Miledi R: Further study ofthe role ofcalcium in synaptic transmission. J Physiol 207:789-801,
1970
4. Tsien RW: Calcium channels in excitable cell membranes. Ann Rev Physiol 45:341-358, 1983
5. Fleckenstein A: Specific pharmacology of calcium in myocardium, cardiac pacemakers and vascular
smooth muscle. Ann Rev Pharmacol 17:149-166, 1977
6. Reuter H: Calcium channel modulation by neurotransmitters, enzymes and drugs. Nature 301:569-
574, 1983
7. Bolger GT, Gengo P, Klockowski R, et al: Characterization of binding of the calcium channel
antagonist, [3H]nitrendipine, to guinea pig ileal smooth muscle. J Pharmacol Exp Therap 225:291-299,
1983
8. Gould RJ, Murphy KMM, Snyder SH: [3H]Nitrendipine-labeled calcium channels discriminate
inorganic calcium agonists and antagonists. Proc Natl Acad Sci USA 79:3656-3660, 1982
9. Nachshen DA, Blaustein MP: Effects of some organic "calcium antagonists" on calcium influx in
presynaptic nerve terminals. Molec Pharmacol 16:579-586, 1979
10. Turner TJ, Goldin SM: Calcium channels in rat brain synaptosomes: Identification and pharmacolog-
ical characterization: High affinity blockade by organic calcium channel blockers. J Neurosci
5:841-849, 1985
11. Braestrup C, Squires RF: Pharmacological characterization of benzodiazepine receptors. Eur J
Pharmacol 48:263-270, 1978
12. Leslie SW, Friedman MB, Coleman RR: Effects ofchlordiazepoxide ondepolarization-induced calcium
influx into synaptosomes. Biochem Pharmacol 29:2439-2443, 1980
13. Ferrendelli JA, Daniels-McQueen S: Comparative actions of phenytoin and other anticonvulsants on
potassium- and veratridine-stimulated calcium uptake in synaptosomes. J Pharmacol Exp Therap
220:29-34, 1982
14. Taft WC, DeLorenzo RJ: Micromolar benzodiazepine receptors regulate voltage-sensitive calcium
channels in nerve terminal preparations. Proc Natl Acad Sci USA 81:3118-3122, 1984
15. Johansen J, Taft WC, Yang J, et al: Inhibition of calcium conductance in identified leech neurons by
benzodiazepines. Proc Natl Acad Sci USA 82:3935-3939, 1985106 TAFT AND DeLORENZO
16. Taft WC, Forman RR, Alkon DL, et al: Benzodiazepines reduce voltage-gated calcium conductance in
Hermissenda neurons. Trans Amer Soc Neurochem 17:250, 1986
17. Sakakibara M, Alkon DL, DeLorenzo RJ, et al: Modulation of calcium-mediated inactivation of ionic
currents by calcium/calmodulin-dependent protein kinase II. Biophys J 50:319-328, 1986
18. Taft WC, Goldenring JR, Buckholz TM, et al: Benzodiazepine inhibition of purified CaM kinase II.
Pharmacologist 27:185, 1985
19. Taft WC, Goldenring JR, DeLorenzo RJ: Molecular mechanisms of neuronal excitability: Possible
involvement of CaM kinase II in seizure activity. In Molecular Mechanisms of Neuronal Responsive-
ness. In press